
Listed on NASDAQ (HLCS) in May 2007
Helicos BioSciences Corporation began operations in February 2004. Helicos is developing instruments and reagents for the high-speed sequencing of DNA and RNA with the highest possible sensitivity. The Helicos technology, based on pioneering research of Dr. Stephen Quake of Stanford University, is covered by a broad portfolio of granted and filed patents. The company commenced early-access collaborations in 2006 to generate ground breaking scientific publications and start creating revenue, while planning to launch its first commercial systems in 2007.